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Objective: To compare the expected and actual pain experienced with the insertion of 
intrauterine contraception in women, and to determine whether either of these are related to 
their personal circumstances, or affected their satisfaction with the procedure.
Design: A convenience sample of 89 women aged 15–50 years attending a sexual health clinic 
for same day intrauterine contraception insertion were given a questionnaire that they com-
pleted following the procedure. The women were asked to rate their expectation of pain prior 
to insertion and to rate the actual pain they experienced immediately after insertion, on a scale 
of 1–10, with 10 being severe pain. Information on the women’s circumstances and their level 
of satisfaction with the procedure was also obtained.
Results: Overall, the median actual pain experienced by women during insertion (4) was 
significantly lower than the expected pain median (6) (P,0.001). For those women who had 
not had a previous vaginal delivery, actual pain was significantly higher compared with women 
who had had a previous vaginal delivery (median [interquartile range]: 6 [3.5–7.5] and 3 [1–5], 
P,0.001, respectively), but there was no significant difference between expected and actual 
pain experiences. In women who had a previous vaginal delivery, actual pain was much lower 
than expected (P,0.001). Neither actual nor expected pain experiences were linked to any other 
sociodemographic reproductive health or service use factors.
Conclusion: All women had a high expectation of pain prior to IUD insertion, but for those 
who had had a previous vaginal delivery, this was significantly greater than that actually 
experienced. Satisfaction levels overall were high. Counseling of women should take into account 
their expected pain prior to IUD insertion and consideration should be given to alternative and 
additional methods of pain relief in women who have not had a previous vaginal delivery.
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Introduction
Intrauterine contraception is highly effective at preventing pregnancy. This long-
acting reversible contraception (LARC) is cost-effective,1 with high continuation 
and satisfaction rates2–5 and few contraindications to its use.6 It also has added 
benefits of either being non-hormonal and as effective as emergency contraception 
(the copper intrauterine device [IUD]) or can be used to reduce menstrual blood 
loss and endometrial proliferation (the levonorgestrel-impregnated IUD). Despite 
these benefits, the last decade has seen little change in the proportion of women 
using intrauterine contraception,7 as many eligible women still do not choose this 
method, perhaps because of their anxiety about pain associated with the insertion 
procedure.Open Access Journal of Contraception 2015:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
22
Brima et al
The scientific literature suggests a continued search for a 
pharmacological means of reducing pain associated with IUD 
insertions. Recent studies have investigated misoprostol,8–12 
lidocaine,13–17 nitroprusside,18 and prophylactic ibuprofen,19–21 
and there are plans to use inhaled nitrous oxide (Entonox®22). 
There is little recent research into women’s pain anxieties 
about the insertion of an IUD.23–26
The expectation of pain can influence the actual pain 
women experience during their IUD insertion.27 Information 
and preparation prior to IUD insertion has been shown to 
reduce anxiety and eventual pain experienced by women 
during their procedure.26 Under current practice women 
receive counseling but the effect on women’s experiences 
and satisfaction with intrauterine contraception insertion 
needs further exploration.
In this study, we sought to determine women’s expected 
pain and actual pain experienced throughout the procedure, 
and if either of these was related to sociodemographic fac-
tors or reproductive history and whether it influenced their 
satisfaction with the IUD insertion procedure.
Design
A convenience sample of 89 women attending the 
Camberwell Sexual Health Clinic based at King’s College 
Hospital, London, for same day IUD insertion was included 
over a 3-month period (between August and October 2011). 
This clinic provides a walk-in service where IUD insertions 
are done (where possible on the same day), for emergency 
contraception, and for ongoing (routine) contraception. Up 
to 100 IUD insertions are done at the clinic each month. 
Although all women who were invited to participate agreed 
to do so, not all eligible women were invited because some 
clinicians were more likely to recruit patients than others. 
Once counseled and having given consent for IUD inser-
tion, the participants were invited to rate how painful they 
expected the procedure was going to be via a self-completed 
questionnaire with a numerical scale of 1–10, where 1 repre-
sented no pain at all and 10 the most severe pain. Participating 
women had the insertions of IUDs for both emergency and 
routine use, including the T-safe® 380A, Nova-T® 380, and 
Mirena® intrauterine system (IUS) for routine use.
Routine clinic procedure for IUD insertion followed. 
This included visualization of the cervix, application of 
tenaculum to the anterior cervical lip, application of 2% 
lidocaine gel via a quill into the cervical canal, sounding 
of the uterus with a plastic sound, and insertion of the IUD. 
A period of 2 minutes was allowed for the lidocaine gel, 
the local anesthetic, to take effect prior to IUD insertion to 
comply with the clinic policy. Women for whom the insertion 
was anticipated to be technically difficult or who preferred 
paracervical block would be rescheduled in a separate 
complex contraception clinic. However, none of our study 
participants required this.
Following IUD insertion and after dressing and being 
seated, participating women were then asked to self-complete 
the second part of the questionnaire, about their experience 
of insertion, including rating the pain they had actually 
experienced on a similar scale to that described previously. 
The questionnaire was then returned to but not reviewed by 
the clinician. Basic sociodemographic factors and reproduc-
tive history were recorded for each patient by the clinician 
using the patients’ clinical records on a separate sheet. The 
clinician also recorded the type of IUD, circumstance of 
insertion (routine or emergency), day of cycle, position of 
uterus, ease of insertion, and their experience in IUD inser-
tion (in terms of number of IUDs ever inserted). Following 
completion by both the patient and the clinician, the ques-
tionnaires were anonymized and were not linked further with 
the patient notes.
Sample characteristics are presented for all participants. 
All women in the sample were included in the analysis. To 
compare pain expectations and experience scores overall and 
within each women’s delivery history groups, the Wilcoxon 
test for matched-pairs was used. The relationships between 
each personal, procedural, and provider’s factors and the 
actual and expected pain were tested using the chi-square 
test. All analysis was performed using StataSE 12. A 5% 
significance level was used.
Results
A total of 89 women who attended the Camberwell Sexual 
Health Clinic for same day IUD insertion were included.
The mean age of the cohort was 32 years old (range: 
15–50 years). Almost half of the group (49%) had expe-
rienced a vaginal delivery in the past and 42% had had an 
IUD/IUS inserted previously (Table 1).
We analyzed the relationship between each demographic 
characteristic listed in Table 1 and the level of pain expected 
and actually experienced (Table 2).
Both actual and expected pains were independent of fac-
tors such as age, race, and previous IUD insertion. Actual 
pain was not related to the type of IUD, reason for insertion 
(routine or emergency), day of cycle, position of uterus or 
doctors’ previous experience. We found that actual pain was 
highly associated with not having experienced a previous 
vaginal delivery (P=0.001; Table 2).Open Access Journal of Contraception 2015:6
Table 1 Characteristics of the sample of 89 womena
Variables Groups n %
Sociodemographic factors
Age, mean (range)
#24 years 
25–34 years 
$35 years
32 (15–50) 
18 
39 
32
 
20 
44 
36
ethnicity White 
Black 
Others
43 
27 
19
48 
33 
22
Reproductive health and service use–related factors
Previous vaginal delivery no 
Yes
45 
43
51 
49
Previous iUD/iUs insertion no 
Yes
52 
37
58 
42
Type of insertion emergency 
routine
15 
70
18 
82
Type of iUD nova-T® 
T-safe® 
iUs
19 
37 
32
22 
42 
36
Position of uterus Anteverted 
retroverted
61 
22
73 
27
Day of cycle 1–5 days 
6–14 days 
15–30 days
17 
32 
19
25 
47 
28
number who have had a previous 
iUD insertion by a clinician
,50 
$50
19 
69
22 
78
Experiences of pain by patients
expected pain, on a scale of 1–10 1 
2 
3 
4 
5 
6 
7 
8 
9 
10
6 
5 
8 
7 
13 
6 
13 
12 
5 
13
7 
6 
9 
8 
15 
7 
15 
13 
5 
15
Actual pain, on a scale of 1–10 1 
2 
3 
4 
5 
6 
7 
8 
9 
10
14 
12 
11 
8 
7 
9 
13 
10 
2 
2
16 
14 
13 
9 
8 
10 
15 
11 
2 
2
Note: aTotal might be less than n=89 due to missing values.
Abbreviations: iUD, intrauterine device; iUs, intrauterine system.
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expected and actual pain during iUD insertion
The overall median of expected pain prior to IUD inser-
tion was statistically significantly higher than the overall 
median of actual pain during IUD insertion (median: 6 and 4, 
P,0.001, respectively; Table 3).
Actual pain was statistically significantly higher for women 
who had not previously had a vaginal delivery compared to 
those who had (median: 6 and 3, P,0.001, respectively). 
For women who had not had a previous vaginal delivery, 
there was no statistically significant difference between 
expected and actual pain experienced (median: 7 and 6, 
P,0.001, respectively). For those women who had expe-
rienced vaginal delivery in the past, actual pain was much 
lower than expected (median: 3 and 6, P,0.001, respectively; 
Table 3).
Most women (93% of participants) would recommend 
IUD insertion to a friend. Satisfaction with the procedure of 
IUD insertion was high – 91% of participants were satisfied 
with the procedure, awarding a score of 7 or higher on the 
scale of 1–10.
Discussion
Findings of this study  
and their interpretation
Our findings show that, overall, women in the study expe-
rienced less pain during their IUD insertion procedure than 
they had expected, but this was only statistically significant 
for women who had previously had a vaginal delivery. For 
women who had had a previous vaginal delivery, their median 
pain score was half of what they had expected. Women who 
had had a previous vaginal delivery therefore appeared to 
overestimate the potential pain of the procedure while the 
pain predicted by women who had not had a previous vaginal 
delivery was in keeping with their actual experience.
There were high numbers of nulliparous and young 
women in our sample compared to the age distribution of 
UK community clinic users,7 which may be due to the fact 
that our population was drawn from an integrated sexual 
health clinic with relatively young patients, that specialist 
sexual health providers may be more likely to offer and fit 
IUDs in young nulliparous women, or a changing demand 
for intrauterine contraception amongst young women.
Despite the pain experienced with IUD insertion, satis-
faction levels with the procedure were very high and did not 
differ for women who did or did not experience severe pain 
during the insertion.
The vast majority of women would recommend IUD 
insertion to a friend.
strengths and limitations of the study
The data was collected as part of an audit. These findings 
are limited by the small convenience sample. However, the 
women were broadly representative of the clinic in terms 
of their sociodemographic factors. Participation was not 
limited by potential difficulty of the procedure but some 
clinicians were more likely to recruit women than others. Open Access Journal of Contraception 2015:6
Table 2 relationships between sociodemographic, reproductive health, and service use factors; and both expected and experienced 
pain by women
Variables Groups Expected pain,  
score .5 (n=49)
P-valuea Actual pain,  
score .5 (n=36)
P-valuea
% (n)b % (n)b
Sociodemographic factors
Age #24 years 
25–34 years 
$35 years
50 (9) 
55 (21) 
59 (19)
0.813 56 (10) 
47 (18) 
25 (8)
0.061
race White 
Black 
Others
59 (25) 
44 (12) 
63 (12)
0.356 45 (19) 
33 (9) 
42 (8)
0.613
Reproductive health and service use-related factors
Previous vaginal delivery no 
Yes
61 (27) 
51 (22)
0.338 59 (26) 
23 (10)
0.001*
Previous iUD/iUs insertion no 
Yes
55 (28) 
57 (21)
0.863 41 (21) 
40 (15)
0.952
Type of insertion emergency 
routine
40 (6) 
39 (27)
0.950
Type of iUD nova-T® 
T-safe® 
iUs
33 (6) 
41 (15) 
47 (15)
0.641
Position of uterus Anteverted 
retroverted
37 (22) 
50 (11)
0.275
Day of cycle 1–5 days 
6–14 days 
15–30 days
29 (5) 
47 (15) 
56 (10)
0.283
number who have had previous  
iUD insertion by a clinician
,50 
$50
33 (6) 
42 (29)
0.503
Notes: aP-value calculated using chi-square test comparing different variables against expected and actually experienced pain (ie, *P-value ,0.001 indicates that women who 
have had a previous vaginal delivery) reported experiencing statistically significantly lower level of pain compared to women who had not had a previous vaginal delivery; brow 
percentages given – the corresponding percentages for expected and actual pain score #5 have been omitted from the table.
Abbreviations: iUD, intrauterine device; iUs, intrauterine system.
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This may have been related to the experience of the partici-
pating clinicians. However, we do not expect this to have 
influenced the characteristics of the women recruited. We 
acknowledge that there could be a group of women who did 
not return to the same clinic for another IUD as a result of 
their experience, and therefore could bias our sample.
Participants were invited to complete the questionnaire 
while still in the same room as the clinician. Whilst these 
women were provided a space to complete this in confi-
dence, it may have influenced the way that the questions 
were answered. However, we believe using the questionnaire 
with a numerical scale in our study was more objective than 
using a visual analog scale (VAS) or a tool that requires 
administration to the patient by the researcher.
Relevance of the findings and  
comparison of the findings  
with those of other studies
Our study findings confirm evidence available from previous 
research on pain during IUD insertion: women experience 
less pain during their IUD insertion procedure than they 
expect;27,28 the actual pain experienced by women during the 
insertion of an IUD is generally low;21 and women who have 
previously had a vaginal delivery are likely to experience 
little and less severe pain during their procedure than their 
nulliparous counterparts.21,29,30
Table 3 expected pain vs actual pain by women’s delivery history
Type of pain No previous 
vaginal  
delivery  
(n=45)
Previous 
vaginal  
delivery  
(n=43)
P-valued Total 
% (n)
expected paina 
Median (iQr)
7 (5–8.5) 6 (3–8) 0.136 6 (4–8)
Actual painb 
Median (iQr)
6 (3.5–7.5) 3 (1–5) ,0.001 4 (2–7)
P-valuec 0.083 ,0.001 ,0.001
Notes:  aOn a scale of 1–10, how painful do you expect your iUD insertion to 
be?; bon a scale of 1–10, what pain did you experience during your iUD insertion?; 
ccalculated  using  Wilcoxon  matched-pairs  signed-rank  test;  dcalculated  using 
Wilcoxon rank-sum test for unmatched pairs.
Abbreviation: iQr, interquartile range.Open Access Journal of Contraception 2015:6 submit your manuscript | www.dovepress.com
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expected and actual pain during iUD insertion
In a similar study conducted by Goldstuck and Matthews27 
in 1985 on nulliparous women, expected pain was sig-
nificantly higher than actual pain experienced (measured 3 
minutes post-insertion), as for our study. Although the devices 
used in that study, the Copper 7® and Copper 7-mini®, are 
less commonly used in practice today, the inserter diameter 
is comparable. Of note is that the pain scores obtained in our 
study were higher than those reported nearly three decades 
ago, despite use of local anesthesia for our cohort. The 
studies are both limited by small sample size and sampling 
techniques and are not directly comparable. However, any 
increase in pain experienced by women having IUD insertion 
compared with those three decades ago may reflect a change 
in pain perceptions or a difference in readiness to report 
pain and discomfort over time. Difference in the insertion 
techniques is also likely to be a factor and the use of local 
anesthetic universally in our study does not appear to have 
counteracted this effect. As yet, there is no evidence that 
Instillagel® significantly reduces pain with IUD insertion, 
although a preliminary randomized study found Instillagel® 
to be effective for IUD insertion pain if it is allowed at least 
5 minutes to take effect.28 However, Instillagel® was only 
allowed 2 minutes to take effect in our study.
As in our study, Carey et al29 found pain with IUD inser-
tion in US women to be significantly lower in those who had 
had a vaginal delivery. Their mean pain scores obtained were 
also comparable – 3.47 in parous women and 5.12 in nul-
liparous, though Carey et al29 used a different tool (0–10 cm 
VAS) to measure pain. However, in the present study, there 
was no insertion difficulty and a greater point difference in 
pain existed between parous and nulliparous women (3.0 in 
this study as opposed to 1.51 by Carey et al).29
recommendations for future  
research and practice
Participants were not asked nor assessed for anxiety prior to 
IUD insertion, which may contribute to pain experienced with 
IUD insertion.26,28,31 However, expected pain has been found 
to be a significant predictor of pain with IUD insertion,29 and 
may in fact be suggestive of anxiety prior to the procedure. 
Counseling prior to IUD insertion, including time to answer 
questions and less formality, discussing what to expect as 
well as pain-reducing and coping strategies, have been shown 
to reduce anxiety and pain experienced with procedures.23,24 
All the women in this study were counseled prior to IUD 
insertion, and irrespective of age, race, parity, or having 
previously had IUD insertion, still appeared to have a high 
expectation of pain prior to their procedure, suggesting that 
women experience high levels of anxiety in relation to IUD 
insertion.
More research is needed on ways to evaluate pain man-
agement strategies for IUD fitting and study the impact of 
expected pain on the actual experience of fitting. This could 
include investigating forms of assessment and intervention 
that may be effective in reducing anxiety prior to insertion that 
could be incorporated routinely. Given the high level of pain 
experienced by women who have not had a previous vaginal 
delivery, consideration should be given to reducing the thresh-
old for local anesthetic use. It would be of interest to ascertain 
whether the way the information is given by a specific care 
provider could influence pain perception and reporting.
Future studies should include information such as a 
psychological assessment of the participants in relation to 
expected and experienced pain.
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